Access cutting-edge heart failure treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapagliflozin, given once daily on top of other classes of SoC, on CV death and HF events.
Sponsor: AstraZeneca
Check if you qualify for this heart failure clinical trial in Beverly Hills, CA
If you're searching for heart failure treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.